Ning Kang

4PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 19, 2025
Exploiting pre-dormancy tumor immune microenvironment induced by androgen deprivation in prostate cancer.

Nelson K Y Wong, Ning Kang, Claire Dourieu

|Jul 14, 2023
Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer.

Ning Kang, Hui Xue, Yen-Yi Lin

|Sep 17, 2020
EZH2 inhibition: a promising strategy to prevent cancer immune editing.

Ning Kang, Mark Eccleston, Pier-Luc Clermont

Pageof 1